Publisher
Springer Science and Business Media LLC
Reference16 articles.
1. Immunotherapy drugs market by type (monoclonal antibodies, check point inhibitors, interferons, and interleukins), therapy area (cancer, autoimmune diseases & inflammatory, infectious diseases), end user (hospitals, clinics ) - Global Forecast to 2025, in Immunotherapy Drugs Market. Market Res Rep. 2020.
2. Yu S, Hubbell JA, Swartz MA. Overcoming transport barriers to immunotherapy. Drug Deliv and Transl Res. 2021. https://doi.org/10.1007/s13346-021-01084-4.
3. Ukidve A, Cu K, Ninad Kumbhojkar N, Lahann J, Mitragotri S. Overcoming biological barriers to improve solid tumor immunotherapy. Drug Deliv and Transl Res. 2021. https://doi.org/10.1007/s13346-021-00923-8.
4. Carney CP, Pandey N, Kapur A, Woodworth GF, Winkles JA, Kim AJ. Harnessing nanomedicine for enhanced immunotherapy for breast cancer brain metastases. Drug Deliv and Transl Res. 2021. https://doi.org/10.1007/s13346-021-01039-9.
5. Ramesh A, Malik V, Ranjani HA, Smith H, Kulkarni AA. Rational combination of an immune checkpoint inhibitor with CSF1R inhibitor–loaded nanoparticle enhances anticancer efficacy. Drug Deliv and Transl Res. 2021. https://doi.org/10.1007/s13346-021-01040-2.